Cargando…
Effects of Kami Guibi-tang in patients with mild cognitive impairment: study protocol for a phase III, randomized, double-blind, and placebo-controlled trial
BACKGROUND: Amnestic mild cognitive impairment (aMCI) is often considered a precursor to Alzheimer’s disease (AD) and represents a key therapeutic target for early intervention of AD. However, no treatments have been approved for MCI at present. Our previous pilot study has shown that Kami Guibi-tan...
Autores principales: | Shin, Hee-Yeon, Yim, Tae-Bin, Heo, Hye-Min, Jahng, Geon-Ho, Kwon, Seungwon, Cho, Seung-Yeon, Park, Seong-Uk, Jung, Woo-Sang, Moon, Sang-Kwan, Ko, Chang-Nam, Park, Jung-Mi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717542/ https://www.ncbi.nlm.nih.gov/pubmed/36461035 http://dx.doi.org/10.1186/s12906-022-03805-9 |
Ejemplares similares
-
Efficacy and safety of Kami-guibi-tang for mild cognitive impairment: a pilot, randomized, double-blind, placebo-controlled trial
por: Shin, Hee-Yeon, et al.
Publicado: (2021) -
Efficacy of Kami Guibi-tang as an Add-On Therapy to Acetylcholinesterase Inhibitor for Cognitive Function in Mild Alzheimer's Disease: A Pilot Study
por: Kim, Ha-Ri, et al.
Publicado: (2023) -
The effectiveness and safety of Kami Guibi-tang for mild cognitive impairment: study protocol of a pilot, randomized, placebo-controlled, double-blind trial
por: Shin, Hee-Yeon, et al.
Publicado: (2019) -
Effect of Kami Guibi-tang (KGT) in elderly subjects with insomnia: a study protocol from a single center, randomized, double-blind, placebo-controlled trial
por: Lee, Kyeong-Hwa, et al.
Publicado: (2023) -
Treatment evaluation of Kami Guibi‐tang on participants with amnestic mild cognitive impairment using magnetic resonance imaging on brain metabolites, gamma‐aminobutyric acid, and cerebral blood flow
por: Cho, Seung‐Yeon, et al.
Publicado: (2021)